Company News

 

January 28, 2002


Notice regarding Purchase of Ono Pharmaceutical's Own Shares in the Market
Ono Pharmaceutical Co., Ltd. has implemented the acquisition of its own shares through the purchase in the market as described below, pursuant to Section 1, Article 3 of the former Special Law regarding Cancellation of Shares due to the application of Section 4, Article 3 of the supplementary provision of the Law regarding the Partial Amendments to the Commercial Code, etc. of Japan. The acquisition was decided at the meeting of the Board of Directors held on November 6, 2001.
     1. Reasons for the acquisition

In order to acquire the Company's own shares by its profits, pursuant to Section 1, Article 3 of the former Special Law regarding Cancellation of Shares due to the application of Section 4, Article 3 of the supplementary provision of the Law regarding the Partial Amendments to the Commercial Code, etc. of Japan.

     2. Implementation

(1) Purchase period : From January 11, 2002 to January 25, 2002
(2) Number of shares purchased : 421,000 shares
(3) Amount of the purchase : 1,681,010,000 yen


      (For reference)
1. The acquisition of the Company's own shares decided at the meeting of the Board of Directors held on November 6, 2001:

(1) Type of shares to be acquired : The Company's common stock
(2) Total number of shares to be acquired : 2,500,000 shares (maximum)
(3) Total acquisition value of shares : 11,000,000,000 yen (maximum)

     2. The Company's provision on cancellation of the Company's own shares, pursuant to the former Special Law regarding Cancellation of Shares:

(1) Total number of shares provided in the Articles of Incorporation of the Company, pursuant to Section 2, Article 3 of the former Special Law regarding Cancellation of Shares : 10,000,000 shares

(2) Aggregate number of shares purchased since the date appointed in the Articles of Incorporation of the Company : 2,500,000 shares

     3. Aggregate number of the Company's own shares purchased between November 7, 2001 and January 25, 2002:

(1) Number of shares purchased : 2,500,000 shares

(2) Amount of the purchase : 9,981,060,000 yen

The Company has completed all the purchase with this transaction for the purpose of the acquisition of its own shares decided at the meeting of the Board of Directors held on November 6, 2001.

      Corporate Information
     Corporate name : Ono Pharmaceutical Co., Ltd.
     Representative : Toshio Ueno, Chairman and CEO
     Stock code : 4528
     Stock listings : First sections of Tokyo Stock Exchange and Osaka Securities Exchange
     Inquiries : Kinya Morimoto, Director, Public Relations
     Tel. : +81-6-6222-5551